BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4455225)

  • 1. NN'-diacetylchitobiase activity in Tay-Sachs disease and Sandhoff's disease.
    Stirling JL
    Biochem J; 1974 Aug; 141(2):597-9. PubMed ID: 4455225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in Tay-Sachs and Sandhoff's diseases. Immunologic and structural properties of hexosaminidase A and hexosaminidase B.
    Beutler E; Srivastava SK
    Isr J Med Sci; 1973; 9(9):1335-7. PubMed ID: 4798071
    [No Abstract]   [Full Text] [Related]  

  • 3. Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease.
    Srivastava SK; Beutler E
    Nature; 1973 Feb; 241(5390):463. PubMed ID: 4122341
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on human beta-D-N-acetylhexosaminidases. 3. Biochemical genetics of Tay-Sachs and Sandhoff's diseases.
    Srivastava SK; Beutler E
    J Biol Chem; 1974 Apr; 249(7):2054-7. PubMed ID: 4206549
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal diagnosis of Sandhoff's disease (GM2-gangliosidosis, type 2)].
    Harzer K; Stengel-Rutkowski S; Gley EO; Albert A; Murken JD; Zahn V; Henkel KP
    Dtsch Med Wochenschr; 1975 Jan; 100(3):106-8. PubMed ID: 234374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tay-Sachs and Sandhoff's disease: intergenic complementation after somatic cell hybridization.
    Galjaard H; Hoogeveen A; de Wit-Verbeek HA; Reuser AJ; Keijzer W; Westerveld A; Bootsma D
    Exp Cell Res; 1974 Aug; 87(2):444-8. PubMed ID: 4416048
    [No Abstract]   [Full Text] [Related]  

  • 9. Inheritance of the enzyme deficiency in three neurolipidoses: variant 0 of Tay-Sachs disease (Sandhoff's disease), classic Tay-Sachs disease, and metachromatic leukodystrophy. Identification of the heterozygous carriers.
    Harzer K
    Humangenetik; 1973; 20(1):9-24. PubMed ID: 4776531
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population.
    Andermann E; Scriver CR; Wolfe LS; Dansky L; Andermann F
    Prog Clin Biol Res; 1977; 18():161-88. PubMed ID: 601075
    [No Abstract]   [Full Text] [Related]  

  • 11. [GM2 gangliosidosis with total beta-N-acetyl-hexosaminidase deficit or Sandhoff's disease].
    Juif JG; Luckel JC; Nussbaum JL; Stoebner R; Kapps R
    Arch Fr Pediatr; 1973 Jan; 30(1):29-43. PubMed ID: 4721586
    [No Abstract]   [Full Text] [Related]  

  • 12. Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.
    Gilbert F; Kucherlapati R; Creagan RP; Murnane MJ; Darlington GJ; Ruddle FH
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):263-7. PubMed ID: 1054503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
    Yuasa T; Fukuma M; Takashima S; Takaki R
    Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyl-beta-hexosaminidase: role in the degradation of glycosaminoglycans.
    Thompson JN; Stoolmiller AC; Matalon R; Dorfman A
    Science; 1973 Aug; 181(4102):866-7. PubMed ID: 4269276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the molecular basis of Sandhoff's disease.
    Ropers HH; Schwantes U
    Humangenetik; 1973; 20(2):167-70. PubMed ID: 4785164
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease.
    Sandhoff K; Harzer K; Wässle W; Jatzkewitz H
    J Neurochem; 1971 Dec; 18(12):2469-89. PubMed ID: 5135907
    [No Abstract]   [Full Text] [Related]  

  • 17. A low-molecular-weight protein cross-reacting with human liver N-acetyl-beta-D-glucosaminidase.
    Carroll M; Robinson D
    Biochem J; 1974 Feb; 137(2):217-21. PubMed ID: 4207386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gangliosidosis with total hexosaminidase deficiency: clinical, biochemical and ultrastructural studies and comparison with conventional cases of Tay-Sachs disease.
    Fontaine G; Résibois A; Tondeur M; Jonniaux G; Farriaux JP; Voet W; Maillard E; Loeb H
    Acta Neuropathol; 1973 Jan; 23(2):118-32. PubMed ID: 4349527
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
    Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
    J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sandhoff's disease (GM2 gangliosidosis, type 2). Clinical, biochemical and anatomo-clinical study].
    Vidailhet M; Neimann N; Grignon G; Hartemann P; Philippart M; Paysant P; Nabet P; Floquet J
    Arch Fr Pediatr; 1973 Jan; 30(1):45-60. PubMed ID: 4721587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.